ESR 13 (CH2)
36 months (Starting date October 2015)
WP3, D3.CH1: Preclinical Imaging and Animal Models – Clinical Translation on ovarian cancer.
CHUV , Switzerland
Type of Position
Early Stage Researcher / PhD Positions
A mobility rule applies to this position. The respective candidate must not have worked for more than 12 months in Switzerland within the last three years. Furthermore, the candidate needs to be in his/her first four years of his/her research career. The four years are counted from the date a degree was obtained which formally entitles to embark on a doctorate.
The ESR will be in charge of performing the translation from a successful preclinical model for diagnosis to a first study in humans, firstly from a diagnostic point of view, and secondarily, as a preclinical therapeutic radioimmunotherapy and then, if feasible into a therapy in humans; The supervisor will train him performing molecular biology and preclinical antibody research on ovarian cancer in mice. At CHUV, preclinical imaging will be done in nuclear medicine with μPET/SPECT/CT, and for clinical trials, PET/CT and SPECT/CT clinical scanners and radiation shielded beds for clinical therapy. The work will be performed at the University hospital of Lausanne.
Expertise in life sciences with strong motivation to be involved in the development of biomedical applications. The candidate would ideally have experience in nuclear medicine. Furthermore, candidates that have some experience (or at least a strong interest) in cell biology will be favoured
According to the Marie Sklodowska-Curie ITN rules: about 4200 CHF/month including mobility allowance or 4700CHF/month including mobility and family allowance (registered partner and/or child).
Enrolment for PhD at
University of Lausanne, Switzerland
Prof. John Prior
Tel: + 41 21 314 43 48
EPFL, Switzerland – 3 months – Tests on pancreatic cancer in mice